Inscripta raises $55.5M to advance gene-editing tech

Inscripta raises $55.5M to advance gene-editing tech

BOULDER -- Inscripta , a leading gene-editing technology company, announced it closed a $55.5 million Series C funding round led by Merieux Developpement and Paladin Capital Group. ... Read More

Wednesday February 28, 2018 0 comments Tags: Boulder, Inscripta, Dr. Kevin Ness, gene editing

IN Sponsors

Content Garden ad

Browse

InnovatioNews ends 9-year run covering Colorado innovation
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
InnovatioNews on Spring hiatus until May 13
InnovatioNews on Spring hiatus until May 13
The Coming Drone Delivery Revolution – What Comes Next?
The Coming Drone Delivery Revolution – What Comes Next?
Primavera Essentials introduces Neuro-Eze
Primavera Essentials introduces Neuro-Eze

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.